The CE/J mouse strain is resistant to Amyloid A protein (AA) amyloidosis. In contrast to AA amyloidosis-susceptible mouse strains that concomitantly express serum amyloid precursor protein (SAA) type 1 and 2 isoforms encoded by the Saa1 and Saa2 genes, respectively, in response to inflammatory stimulation from the liver, CE/J mice express only a single SAA isoform named SAA2.2. In addition, CE/J mice uniquely possess a Q30L amino acid substitution in SAA2.2 that inhibits amyloidogenesis. To elucidate the genetic basis underlying the expression of only a single SAA isoform in this strain, we conducted PCR cloning and nucleotide sequencing of the Saa1 and Saa2 genes from the CE/J genome. We revealed that CE/J mice possess functional Saa1 and Saa2 genes. Intriguingly, the 2 genes were identical with respect to amino acid sequence, each encoding the SAA2.2 isoform.
Introduction
Mice provide a useful model system for the study of Amyloid A protein (AA) amyloidosis, a disorder characterized by the buildup of insoluble serum amyloid A precursor proteins (SAA) following inflammation. In susceptible mouse strains such as BALB/c and C57BL/6J, experimental AA amyloidosis can be conventionally induced within 1 week after the administration of an inflammatory agent and an amyloid enhancing factor. In contrast, the CE/J strain is resistant to AA amyloidosis [1] . It has been shown that AA amyloid deposits are absent in CE/J mice even after 50 injections of an inflammatory agent administered over 60 days [1] .
Whereas AA amyloidosis-susceptible mouse strains codominantly express SAA1 and SAA2 isoforms in response to inflammatory stimulation, the resistance of CE/J mice to AA amyloidosis is considered to be due to the expression of a single unique SAA isoform [2] . SAA proteins are encoded by the Saa1 and Saa2 genes, which belong to an ancient gene family found in all mammalian species examined thus far. Saa1 and Saa2 genes are thought to have been formed through gene duplication, and gene conversion between the 2 duplicated loci has contributed to a high degree of sequence similarity. The mouse Saa1 and Saa2 genes are ~3.5 kilobase (kb) pairs in length and are located within an interval of ~8 kb on chromosome 7 [3] . The overall exon/intron organization of the 2 genes is highly similar.
Furthermore, the reference Saa1 and Saa2 genes of the C57BL/6J mouse strain retain 96% nucleotide sequence identity over their entire length. At the protein level, the 122 amino acid-long reference SAA1.1 (accession number NP_033143) and SAA2. 1 (NP_035444) proteins are similar, with differences at only 9 positions (25th, 26th, 46th, 49th, 50th, 79th, 82nd, 95th, and 120th) [4] (Figure 1 ). Unlike AA amyloidosis-susceptible mouse strains, only a single SAA (named SAA2.2) has been observed in the plasma of acute phase CE/J mice [1] .
The SAA2.2 has a complex composite pattern of the 9 polymorphic amino acids between the reference SAA1.1 and SAA2.1 sequences noted above [2] (Figure 1 ). Most importantly, SAA2.2 also possesses a unique leucine residue at position 30; a glutamine residue is present at this position in the conventional mouse SAA1 and SAA2 isoforms ( Figure 1 ). It has been postulated that this Q30L amino acid substitution inhibits amyloidogenesis of the SAA2.2 isofom [2] .
Thus, even though the biochemical basis of resistance to AA amyloidosis in CE/J has been well characterized, the primary genetic cause for the apparent absence of one of the SAA isoforms in the CE/J plasma has not yet been determined. One possibility is that one of the Saa genes of the strain is transcriptionally silent. Consistent with this hypothesis, a previous study resulted in the isolation of a cDNA clone for SAA2.2, but not for the putative SAA1 isoform [2] . Transcriptional induction of the mouse Saa1 and Saa2 genes is regulated by 2 cis-acting elements of a CAAT enhancer-binding protein  (C/EBP)-binding motif and a nuclear factor B (NF-B)-binding motif located in tandem within 260 bp upstream of the first non-coding exon of the genes [5] . A proinflammatory cytokine IL-6 enhances gene transcription via the C/EBP-binding motif, whereas IL-1 and TNF-α enhance transcription via the NF-B-binding motif. We postulated that CE/J mice have a defect in these elements, or, that one of the Saa genes has been lost from the CE/J genome. To explore these possibilities, we cloned and characterized complete sequences of the Saa1 and Saa2 genes from the CE/J genome, including all exons and introns, the upstream enhancer/promoter regions, and downstream polyadenylation signal sequences.
Materials and Methods
PCR cloning and nucleotide sequence analysis of the Saa1 and Saa2 genes from a CE/J mouse All experimental procedures involving mice were carried out in accordance with the Regulations for Animal Experimentation of Shinshu University. CE/J mice were purchased from the Jackson laboratory. Genomic DNAs were isolated from the liver by using a standard method. The mouse Saa1 and Saa2 genes have high nucleotide sequence similarity in the region between approximately 290 base pairs (bp) 5′ to the transcription start site and 450 bp 3′ to the polyadenylation signal of the genes [3] . To ensure specific, full-length PCR cloning of Saa1 and Saa2, oligonucleotide primers (mgSaa1-F, mgSaa1-R, mgSaa2-F, and mgSaa2-R) were designed such that the primers could anneal to the non-homologous 5′-upstream and 3′-downstream regions of the genes. mgSaa1-F and mgSaa1-R are located at 603 bases upstream of the transcription start site and 504 bases downstream of the polyadenylation signal of Saa1, respectively. mgSaa2-F and mgSaa2-R are located at 604 bases upstream of the transcription start site and 1018 bases downstream of the polyadenylation signal of Saa2, respectively. The nucleotide sequences and locations of the primers in the mouse genome assembly (GRCm37/mm9) were as follows: mgSaa1-F: 5′-CCCAAGAGCTGAGAACTTATGCTAG-3′ (53998977-53998953) mgSaa1-R: 5′-ACTGCACAGGACTTGCCCAATC-3′ (53995360-53995381) mgSaa2-F: 5′-CCCTCTCCATATTAGTGTGGATTGTC-3′ (54006575-54006599) mgSaa2-R: 5′-GGACTCAGTGCAAGTCAAACAG-3′ (54010683-54010662)
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The expected sizes of the PCR products were 3618 bp for Saa1 and 4109 bp for Saa2.
PCR amplification was performed using a TaKaRa LA Taq DNA polymerase (TAKARA BIO INC., Otsu, Japan) following the manufacturer's instructions with modifications. A 25-µL reaction volume was used for PCR. The cycling parameters for PCR consisted of an initial denaturation for 1 min at 94°C, followed by 35 cycles of 20 s at 94°C, 15 s at 55°C, and 4 min at 72°C. The PCR products were purified using an UltraClean PCR Clean Up Kit (Mo Bio Laboratories, Carlsbad, CA) and sequenced using a BigDye Cycle Sequencing FS Ready Reaction Kit (Life Technologies, Grand Island, NE) and an ABI 310 automated sequencer (Life Technologies). Entire nucleotide sequences of the PCR products were determined by sequence walking.
Reverse Transcription PCR analysis for Saa gene expression
Two-month-old CE/J mice (n=6) were subcutaneously administered 0.5 mL of 2% silver nitrate solution and 100 µg of AA amyloid fibrils intravenously. Three mice were euthanized the next day, and the livers were collected. mRNA was extracted from the livers with the QuickPrep Micro mRNA Purification Kit (GE Healthcare Bio-Sciences, Piscataway, NJ).
First-strand cDNA was synthesized using a First-Strand cDNA Synthesis Kit (GE Healthcare Bio-Sciences). cDNA fragments for the Saa genes were then amplified by PCR by using the primer pair Saa-exon2F (5′-GGTTTTTTTCATTTGTTCACGAGGC-3′) and Saa-DownR2 the Dual-Luciferase Reporter Assay System (Promega). Analysis of variance was used to examine any significant differences in enhancer activity among the subjects. Subsequent post-hoc tests to determine significant differences in the pair-wise comparisons were performed using the Tukey-Kramer test. Assays were conducted in triplicate, and the experiments were repeated 3 times.
Results

CE/J mice have Saa1 and Saa2 genes that encode identical SAA2.2 isoforms
We obtained PCR products for both Saa1 and Saa2 from the CE/J genome by using primers specific for each gene. The PCR products contained putative upstream regulatory elements Tables 1 and 2 ). The nucleotide sequence of Saa1 and Saa2 of 9 CE/J showed high overall similarity ( Figure 2A) . Intriguingly, the coding sequences of the Saa1 and Saa2 PCR products were identical except for one silent nucleotide substitution in the 59th codon (AAC in Saa2 and AAT in Saa1). Both Saa1 and Saa2 PCR products had a strain-specific nucleotide substitution that gave rise to the Q30L amino acid substitution unique to the SAA2.2 isoform [2] . However, the Saa1 and Saa2 PCR products from CE/J showed differences at 15 positions in the sequence between the termination codon and polyadenylation signal (Figure 2A ).
These nucleotide differences allowed us to distinguish transcripts derived from the 2 genes. Indeed, RT-PCR products obtained from the acute phase liver of all 3 CE/J mice contained both Saa1 and Saa2 sequences ( Figure 2B ), indicating that the Saa1 gene was actually transcribed in the liver of the CE/J mice under inflammatory conditions. The peak heights of chromatograms were almost equal for the Saa1 and Saa2 products. Furthermore, when the PCR products were TA-cloned into the plasmid vector, 27 and 21 of 48 recombinant plasmids contained PCR products for Saa1 and Saa2, respectively, suggesting that the 2 genes were expressed at equivalent levels. These results indicate that the seemingly single SAA2.2 isoform of the CE/J mice is likely a mixture of Saa2 and Saa1 gene products that have identical amino acid sequences.
Despite the observed expression of both Saa2 and Saa1, CE/J mice did not have AA amyloidosis (data not shown); this finding is consistent with a previous report [1] .
Promoter/enhancer sequence of Saa1 and Saa2 genes of CE/J are functional
To confirm the transcriptional capacity of Saa1 and Saa2 in CE/J mice, we characterized the upstream promoter/enhancer regions of the genes. Major laboratory mouse strains are classified as carrying the A haplotype (e.g., BALB/c) or B haplotype (e.g., 129/Ola) of the Saa1 and Saa2 gene unit [6] . A previous study revealed nucleotide sequence polymorphisms (either ggagtTttCc or ggagtAttAc) in the NF-B-binding motif of the mouse Saa1 and Saa2
genes that influenced the effects of IL-6 and IL-1 in a promoter/enhancer reporter assay in vitro [5] . Strains of A haplotype have the ggagtTttCc and ggagtAttAc sequences in Saa1 and
Saa2 genes, respectively. On the other hand, strains of B haplotype have the ggagtTttCc and ggagtAttAc sequences in Saa2 and Saa1 genes, respectively. In contrast to these mouse strains, it was found that CE/J mice had the ggagtAttAc sequence in both the Saa1 and Saa2 genes ( Figure 3A ). In addition, we found a nucleotide substitution (Gattgcacaatga) in the C/EBP-binding motif of the Saa2 gene of CE/J ( Figure 3A ).
In a previous study, the use of promoter/enhancer reporter assay demonstrated that BALB/c Saa1 gene expression was synergistically upregulated by IL-1 working on the NF-B-binding motif and IL-6 working on the C/EBP-binding motif [5] ( Figure 3B ). We prepared reporter plasmid constructs for Saa2 (Type-2.2) and Saa1 (Type-2.1) upstream sequences of CE/J, and the enhancer activity was compared to that of BALB/c Saa1 (Type-1).
Synergistic upregulation by IL-1 and IL-6 were not observed for the Type-2.2 and Type-2.1
constructs. Both constructs, however, showed moderate responses to IL-6 similar to the Type-1 construct ( Figure 3B ). These results indicate that the promoter/enhancer sequence of 
Discussion
The data presented in this study indicate that the apparent absence of one of the SAA isoforms in the CE/J plasma is because both Saa1 and Saa2 genes in the strain code for the identical SAA2.2 isoform. To the best of our knowledge, this is the first example of an Saa1 and Saa2 gene unit/ haplotype that encodes 2 identical SAA isoforms. This is in contrast to the SAA1 and SAA2 isoforms described in standard laboratory mouse strains, which have amino acid differences at 9 positions. Moreover, human SAA1 and SAA2 isoforms have amino acid differences at 6 positions.
The extremely high similarity of Saa1 and Saa2 coding sequences of CE/J has likely been attained through gene conversion. It has been postulated that a Q30L amino acid substitution in the SAA2.2 isoform inhibits its amyloidogenesis [2] . The nucleotide substitution for the Q30L amino acid substitution is present in both Saa1 and Saa2 of CE/J. It is highly unlikely that identical nucleotide substitution occurred independently in 2 genes. Rather, it is reasonable to consider that the nucleotide substitution was transferred from one of the genes (Saa2) to the other (Saa1) through a gene conversion event.
Whether CE/J mice are advantaged or disadvantaged as a result of possessing only a single SAA isoform is not clear. The SAA proteins are an acute phase apolipoprotein reactant.
However, the precise physiological/functional differences between SAA1 and SAA2 are not well understood. An advantage of CE/J mice in experimental medicine is that they do not develop AA amyloidosis [1] . Thus, the mouse strain provides an excellent model system for the study of amyloid enhancing factors other than AA fibril in AA amyloidosis [7] .
Furthermore, it has been shown that AA can cross-seed and cross-compete with other amyloid fibrils, such as that observed for the AApoAII in an induced amyloidosis mouse model [8] .
The interference by AA could, in some cases, impede the correct interpretation of data obtained from these models. CE/J or congenic strains in which the Saa gene unit of CE/J is introduced onto the background of different mouse strains should be potentially more relevant models for studies where such interference by AA should be avoided. It is necessary to discriminate heterozygous carrier mice of the CE/J Saa allele to breed congenic strains. The nucleotide sequence data of Saa genes of CE/J should be useful for breeding such congenic mouse strains.
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